,drugId,displayName,indication,company,country,probabilityOfSuccess,phase,startDate,endDate,successPercentage
5,54730,sotatercept,Pulmonary artery hypertension,Merck & Co Inc,US,92%,Pre-Reg,30-Jun-2023,25-Mar-2024,92%
